The amount of plasminogen, tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in human thrombi and the relation to ex-vivo lysibility.

Potter van Loon, B J; Rijken, D C; Brommer, E J; van der Maas, A P

Potter van Loon, B J; Rijken, D C; Brommer, E J; van der Maas, A P.

Affiliation

Potter van Loon BJ; Westeinde Hospital, Dept. of Internal Medicine, Den Haag, The Netherlands.

Thromb Haemost ; 67(1): 101-5, 1992 Jan 23.

Article in En | MEDLINE | ID: mdl-1615463

Subject(s)

Plasminogen Inactivators/metabolism; Plasminogen/metabolism; Thrombosis/metabolism; Tissue Plasminogen Activator/metabolism; Humans; In Vitro Techniques; Thrombolytic Therapy; Thrombophlebitis/drug therapy; Thrombophlebitis/metabolism; Thrombosis/drug therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Plasminogen / Thrombosis / Plasminogen Inactivators / Tissue Plasminogen Activator Limits: Humans Language: En Journal: Thromb Haemost Year: 1992 Document type: Article Affiliation country: Netherlands Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links